|
Donanemab slows cognitive decline in trials
|
|
Resverlogix Corp.
|
Mar 21, 2021 03:12AM
|
|
BET inhibition and neuropathic pain
|
|
Resverlogix Corp.
|
Apr 06, 2021 12:38AM
|
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
|
Resverlogix Corp.
|
Feb 12, 2021 05:08PM
|
|
Domain-selective targeting of BET proteins in cancer and immunological diseases
|
|
Resverlogix Corp.
|
Apr 02, 2021 04:34AM
|
|
BRD4: An emerging prospective therapeutic target in glioma
|
|
Resverlogix Corp.
|
Apr 02, 2021 04:45AM
|
|
Re: BETonMACE ClinicalTrial.gov updated
|
|
Resverlogix Corp.
|
Sep 29, 2017 05:56PM
|
|
BET inhibition and breast cancer
|
|
Resverlogix Corp.
|
Apr 13, 2021 06:46AM
|
|
Any relation or possible future collab?
|
|
Resverlogix Corp.
|
Mar 19, 2021 12:00AM
|
|
Gender differences in responses to BET inhibition
|
|
Resverlogix Corp.
|
Apr 29, 2021 08:32AM
|
|
Nerve Growth Factor for Alzheimer's
|
|
Resverlogix Corp.
|
Dec 07, 2019 03:20PM
|
|
Choline and ApoE4
|
|
Resverlogix Corp.
|
Mar 16, 2021 12:51PM
|
|
Dementia complicated by Stroke/MI/CVD
|
|
Resverlogix Corp.
|
Jul 01, 2017 02:25AM
|
|
Not an RVX thing but addresses diabetes, weight, and fatty liver
|
|
Resverlogix Corp.
|
Jun 29, 2023 02:48PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
|
Resverlogix Corp.
|
Sep 25, 2017 09:32PM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
|
Resverlogix Corp.
|
Sep 25, 2017 09:51PM
|
|
Epigenetic Markers of Alzheimers
|
|
Resverlogix Corp.
|
Dec 07, 2019 11:17PM
|
|
A few articles on trial delays due to COVID
|
|
Resverlogix Corp.
|
Sep 16, 2021 06:30AM
|
|
Aug 29 Article Abstract - European Heart Journal (Case Reports?)
|
|
Resverlogix Corp.
|
Sep 26, 2017 08:51AM
|
|
Monoclonal Antibody Treatment
|
|
Resverlogix Corp.
|
Sep 16, 2021 06:44AM
|
|
Intetesting. Oncohistones
|
|
Resverlogix Corp.
|
Jun 19, 2021 02:21AM
|
